Partial Loss of Function ABCA12 Mutations Generate Reduced Deposition of Glucosyl-Ceramide, Leading to Patchy Ichthyosis and Erythrodermia Resembling Erythrokeratodermia Variabilis et Progressiva (EKVP).
ABCA12
EKVP
erythroderma
glucosyl-ceramide
harlequin ichthyosis
hyperkeratosis
ichthyosis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Sep 2023
11 Sep 2023
Historique:
received:
18
07
2023
revised:
25
08
2023
accepted:
06
09
2023
medline:
29
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Ichthyoses are genetically determined cornification disorders of the epidermis characterized by the presence of different degrees of scaling, hyperkeratosis, and erythroderma often associated with palmoplantar keratoderma. Different classifications of these diseases have been proposed, often based upon the involved genes and/or the clinical presentation. The clinical features of these diseases present some overlap of phenotypes among distinct genetic entities, depending mainly on the penetrance of mutations. In this study, using a clinical, genetic, and molecular approach, we analyzed a family with two affected members who had clinical and histological features resembling erythrokeratodermia variabilis (EKV) or a type of erythrodermic hyperkeratosis with palmoplantar keratoderma. Despite of the clinical presentation, we demonstrated that the affected patients were genetically double heterozygous for two different mutations in the
Identifiants
pubmed: 37762265
pii: ijms241813962
doi: 10.3390/ijms241813962
pmc: PMC10530436
pii:
doi:
Substances chimiques
Glucosylceramides
0
ABCA12 protein, human
0
ATP-Binding Cassette Transporters
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Eur J Dermatol. 2009 Mar-Apr;19(2):114-8
pubmed: 19106041
Am J Hum Genet. 2005 May;76(5):794-803
pubmed: 15756637
J Invest Dermatol. 2006 Nov;126(11):2408-13
pubmed: 16902423
Nat Genet. 1998 Dec;20(4):366-9
pubmed: 9843209
Am J Med Genet A. 2011 Dec;155A(12):3104-9
pubmed: 22069181
Acta Derm Venereol. 2020 Mar 25;100(7):adv00095
pubmed: 32147742
J Invest Dermatol. 1997 Mar;108(3):357-61
pubmed: 9036939
J Invest Dermatol. 2004 Mar;122(3):837-9
pubmed: 15086573
PLoS One. 2018 Apr 24;13(4):e0195792
pubmed: 29689068
Biochim Biophys Acta. 2014 Mar;1841(3):435-40
pubmed: 23954554
J Dermatol Sci. 2010 Nov;60(2):128-9
pubmed: 20869849
Cell Death Differ. 2006 Jun;13(6):1037-47
pubmed: 16601749
J Invest Dermatol. 2003 Apr;120(4):601-9
pubmed: 12648223
Folia Biol (Praha). 2019;65(4):170-180
pubmed: 31903890
J Invest Dermatol. 2000 Jun;114(6):1136-40
pubmed: 10844556
Clin Exp Dermatol. 2011 Jun;36(4):406-11
pubmed: 21564177
J Invest Dermatol. 2005 Jan;124(1):268-9; author reply 270-1
pubmed: 15654984
Prog Med Genet. 1976;1:185-210
pubmed: 935508
Am J Hum Genet. 1997 Sep;61(3):581-9
pubmed: 9326323
Allergy Asthma Immunol Res. 2014 Jul;6(4):276-87
pubmed: 24991450
Br J Dermatol. 1999 May;140(5):815-28
pubmed: 10354017
Am J Hum Genet. 1999 Mar;64(3):732-8
pubmed: 10053007
J Am Acad Dermatol. 2010 Oct;63(4):607-41
pubmed: 20643494
Am J Hum Genet. 2000 Nov;67(5):1296-301
pubmed: 11017804
Br J Dermatol. 2011 Feb;164(2):442-7
pubmed: 21271994
Br J Dermatol. 2020 Jan;182(1):208-211
pubmed: 31206590
J Invest Dermatol. 2015 Jun;135(6):1540-1547
pubmed: 25398053
J Clin Invest. 2005 Jul;115(7):1777-84
pubmed: 16007253
J Pathol. 2004 Nov;204(4):355-66
pubmed: 15495218
Hum Mol Genet. 2002 May 15;11(11):1311-6
pubmed: 12019212
Acta Derm Venereol. 2020 Mar 25;100(7):adv00096
pubmed: 32147747
Histochem Cell Biol. 2008 Jun;129(6):705-33
pubmed: 18461349
Eur J Dermatol. 2014 Nov-Dec;24(6):703-4
pubmed: 25514680
Exp Dermatol. 1996 Dec;5(6):297-307
pubmed: 9028791
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):329-34
pubmed: 16101542
J Invest Dermatol. 2001 Dec;117(6):1391-6
pubmed: 11886499
Int J Mol Sci. 2020 Feb 11;21(4):
pubmed: 32054030